Articles tagged "Kidney/liver transplantation"

2018 American Transplant Congress
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Liver/Kidney Transplantation
U. Gautam, T. Reichman, J. Yu, S. Koppu, D. Bandyopadhyay, M. Levy, G. Gupta, L. Kamal.
Virginia Commonwealth University, Richmond, VA.
Introduction: There is no data on the risks and benefits of induction immunosuppression in simultaneous liver/kidney transplant (SLKT) patients.Methods: We analyzed all SLKT performed between…
2018 American Transplant Congress
Kidney Quality Influences Patient and Graft Survival in Liver Transplant Recipients with End Stage Renal Disease
J. Reyes, M. Eerhart, J. Danobeita, P. Chlebeck, L. Zitur, L. Fernandez.
Surgery, University of Wisconsin, Madison.
Background: Recent changes in the allocation policy established by UNOS created a competitive algorithm that facilitates the placement of kidneys in liver transplant recipients that…
2018 American Transplant Congress
No Deleterious Effect from the Presence of Donor Specific Antibodies (DSA) or Positive Flow Cytometry Crossmatch (FCXM) on the Outcomes of Simultaneous Liver-Kidney (SLK) Transplant Recipients
H. Khamash, A. Kumar, B. Aqel, R. Heilman, A. Jaramillo, K. Reddy, A. Moss.
Mayo Clinic Arizona, Phoenix.
SLK transplant recipients have excellent outcomes that rival kidney alone recipients in terms of graft and patient survival and have better outcomes in terms of…
2018 American Transplant Congress
Basiliximab Induction in Simultaneous Liver-Kidney Transplant
C. Song, X. Luo, L. Pote, S. Strout, D. Segev, N. Desai, A. Gurakar, F. Navqi, J. Garonzik Wang.
The Johns Hopkins Hospital, Baltimore.
Rabbit anti-thymocyte globulin (rATG) is the most common induction agent in renal transplant recipients; however, induction agent selection for SLK recipients is not well described.…
2018 American Transplant Congress
Receiving Hypertensive Donor Has an Inferior Prognosis in Simultaneous Liver Kidney Transplantation Recipient
Z. Guo, Z. Zhu, S. Huang, Y. Tang, Z. Zhang, X. He, G. Chen.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Background: The impacts of hypertensive (HTN) donor on the prognosis of simultaneous liver kidney transplantation (SLKT) patient are not known to date, and an applicable…
2018 American Transplant Congress
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers
A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Mayo Clinic, Rochester, Phoenix, Jacksonville.
Background: Excess opiate prescribing has led to an epidemic, and evidence to guide abdominal transplant practice is lacking. We aimed to identify variation in opiate…
2018 American Transplant Congress
Transplantation of DCD Livers vs. NDD and LDLT: Is There a Difference in Post-Transplant Kidney Dysfunction?
D. Kollmann,¹ S. Neong,¹ R. Rosales,¹ G. Sapisochin,¹ M. Bhat,¹ M. Cattral,¹ P. Greig,¹ L. Lilly,¹ D. McGilvray,¹ A. Ghanekar,¹ D. Grant,¹ M. Selzner,¹ F. Wong,² N. Selzner.¹
¹Multi Organ Transplant, Toronto General Hospital, Toronto, Canada; ²Division of Gastroenterology, Toronto General Hospital, Toronto, Canada.
Background. Recipients of donation after circulatory death (DCD) grafts are reportedly at higher risk of developing post liver transplant (LT) renal dysfunction. Our aim was…
2018 American Transplant Congress
An Early Look at the OPTN's New SLK Allocation Policy
A. Kucheryavaya,¹ R. Formica,² N. Turgeon,³ D. Stewart,¹ A. Wilk.¹
¹UNOS, Richmond; ²Yale School of Medicine, New Haven; ³Emory Univ Hosp, Atlanta.
Background: The new Simultaneous Liver-Kidney (SLK) allocation policy went into effect on 8/10/17. It established renal medical criteria for patients waiting for SLK transplants and…
2018 American Transplant Congress
Assessment of Donor Specific Anti-HLA Antibodies throughout SLK Transplantation
P. Jindra, M. Kueht, S. Gray, D. Giang, M. Cusick, A. Rana, B. Murthy, W. Etheridge, J. Goss, R. Kerman.
Division of Abdominal Transplantation and Hepatobiliary Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
Simultaneous Liver-Kidney transplantation provides a mechanism to protect the transplanted kidney from recognition by the recipient's immune response compared to solitary kidney transplant alone. High…
2018 American Transplant Congress
Liver Retransplantation and Renal Failure: The Benefit of Simultaneous Kidney Transplant
J. Berumen,¹ V. Irine,² S. Mita,² S. Gabriel,¹ M. Kristin.¹
¹Department of Surgery, University of California San Diego, San Diego, CA; ²Department of Medicine, University of California San Diego, San Diego, CA.
Liver retransplantation has poor survival compared to primary liver transplant. Renal failure is a proven negative risk factor for survival with retransplant. Our aim was…